#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Precursor T-lymphoblastic lymphoma/leukaemia recurrent Philadelphia positive chronic myeloid leukaemia Hodgkin's disease Vulval cancer Neurotrophic keratopathy Testicular leiomyosarcoma Fontan procedure Squamous cell carcinoma of head and neck Lupus nephritis Chronic myeloid leukaemia (in remission) Von Willebrand's disease Nephrotic syndrome Deafness Glomerulonephritis acute Heritable pulmonary arterial hypertension More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Diagnostics Short-bowel syndrome – Treatment Retinoblastoma – Life with Disease Hereditary neuropathic amyloidosis – Trials in Disease Marfan’s syndrome SAPHO syndrome – Diagnostics Primary hyperoxaluria Hypereosinophilic syndrome SAPHO syndrome Mitochondrial myopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avacincaptad Pegol VTX2735 SODIUM Utreglutide Op-1250 Dexlansoprazole ANERATRIGINE MESILATE Selinexor ALLERGEN EXTRACTS Eye103 Lumasiran Histamine Dihydrochloride Bi 764532 Glenzocimab Eliglustat Tartrate Colecalciferol Rbl027.2 IM-101 Tolinapant Lactate Potassium Iodide Carbetocin More therapies…

    Learn about Your Condition

    Small intestine leiomyosarcoma Subdural haematoma Aortic valve stenosis Dilated cardiomyopathy Endometrial cancer metastatic Cartilage injury Heart transplant Eosinophilic oesophagitis Lung transplant Immune-mediated enterocolitis Head and neck cancer stage IV Inborn error of metabolism Corneal graft rejection Sjogren's syndrome Lung neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Effectiveness of PLX-PAD Cells for Patients with Mild to Moderate Knee Osteoarthritis

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Emiplacel
    • Cetirizine Dihydrochloride
    Germany

  • Study of INCB099280 and Adagrasib for Adults with Advanced Solid Tumors with KRASG12C Mutation

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Incb099280
    • Adagrasib
    France Italy Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Jnj-77242113
    • Deucravacitinib
    Germany Hungary Italy Poland Romania Spain

  • Study on Temporarily Stopping Duloxetine, Sertraline, and Paroxetine in Patients with Hip or Knee Osteoarthritis Undergoing Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Knee arthroplasty
    • Hip arthroplasty
    Investigated Drugs:
    • Citalopram
    • Citalopram Hydrobromide
    • Duloxetine
    Denmark

  • Study on the Safety of Glucothera Plus for Children with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Sodium Lactate
    • Calcium Chloride Dihydrate
    • Glucose Monohydrate
    Italy

  • Study on the Effectiveness and Safety of Stem Cell Therapy for Urinary Incontinence in Patients After Prostate Surgery

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Urinary incontinence
    Investigated Drugs:
    • Autologous Adipose-Derived Mesenchymal Stem Cells In Vitro Expanded
    • Sodium Chloride
    Poland
Previous Page
1 … 871 872 873 874 875 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!